Evaluation of Bone Mineral Density in Iranian HIV/AIDS Patients

Badie, Banafsheh Moradmand; Soori, Tahereh; Kheirandish, Parastoo; Izadyar, Saeed; SeyedAlinaghi, SeyedAhmad; Foroughi, Maryam; Rostamian, Alireza; Mohraz, Minoo
August 2011
Acta Medica Iranica;2011, Vol. 49 Issue 7, p460
Academic Journal
Bone disorders have emerged as a worrisome complication in HIV-infected patients in recent years. It is not clear that HIV infection itself or antiretroviral treatment or both are causes of bone loss. However, most studies have found a high prevalence of osteopenia and osteoporosis in HIV/AIDS patients. The objectives of this study were to determine the prevalence of osteopenia and osteoporosis in HIV-infected patients either untreated or receiving Highly Active Antiretroviral Therapy as compared with HIV negative persons. We also assessed the factors associated with these conditions. Bone Mineral Density was assessed by Dual Energy X-Ray Absorptiometry scans at the hip and lumbar spine in 36 AIDS patients receiving antiretroviral therapy and 44 HIV infected patients not receiving antiretroviral therapy (naïve patients) and 40 HIV negative individuals as control. Factors that affect BMD were also determined. Prevalence of osteopenia or osteoporosis in different regions was significantly higher in HIV/AIDS patients compared with HIV negative subjects (77.3% in HIV positive naïve patients, 86.1% in HAART-treated patients and 60% in the control group, P=0.002). Mean serum alkaline phosphatase was higher in HIV/AIDS patients than the control group (P=0.003). Osteopenia and osteoporosis in HIV-infected patients were associated with duration of HIV infection (P<0.0001) and antiretroviral treatment (P=0.012). Prevalence of osteopenia and osteoporosis in HIV/AIDS patients was higher than HIV negative individuals. Osteopenia and osteoporosis in HIV/AIDS patients was associated with duration of HIV infection and antiretroviral treatment.


Related Articles

  • Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers. McComsey, Grace A.; Tebas, Pablo; Shane, Elizabeth; Yin, Michael T.; Overton, E. Turner; Huang, Jeannie S.; Aldrovandi, Grace M.; Cardoso, Sandra W.; Santana, Jorge L.; Brown, Todd T. // Clinical Infectious Diseases;10/15/2010, Vol. 51 Issue 8, p937 

    Low bone mineral density (BMD) is prevalent in human immunodeficiency virus (HIV)-infected subjects. Initiation of antiretroviral therapy is associated with a 2%-6% decrease in BMD over the first 2 years, a decrease that is similar in magnitude to that sustained during the first 2 years of...

  • HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV Infection. Del Carpio-Cano, Fabiola E.; DeLa Cadena, Raul A.; Sawaya, Bassel E. // Journal of Osteoporosis;2013, p1 

    Increased life expectancy and the need for long-termantiretroviral therapy have brought newchallenges to the clinical management of HIV-infected individuals. The prevalence of osteoporosis and fractures is increased in HIV-infected patients; thus optimal strategies for risk management and...

  • High Rate of Bone Thinning in People With Long Antiretroviral Treatment.  // HIV Treatment ALERTS!;Mar2011, p12 

    The article presents a study on the effect of antiretroviral therapy on the high rate of bone thinning among HIV patients in Spain. The study found a link between low mineral density and treatment with Viread or protease inhibitors. The study also identified other risk factors for osteopenia or...

  • A case of march fracture in a patient with osteoporosis on long-term HAART. Forsyth, Sophie F.; Gazzard, Brian G.; Nelson, Mark R. // International Journal of STD & AIDS;Sep2002, Vol. 13 Issue 9, p645 

    The article discusses the consideration of osteoporosis as a diagnosis in patients with HIV infection. A 50-year-old man, who was given a highly active antiretroviral therapy, was gathered with data on the nature and effects of the treatment. Results indicate that HIV-infected patients are prone...

  • Bone disease in HIV infection. Saccomanno, Maristella Francesca; Ammassari, Adriana // Clinical Cases in Mineral & Bone Metabolism;2011, Vol. 8 Issue 1, p33 

    The advent of highly active anti-retroviral therapy (HAART) has dramatically decreased the rate of AIDS-related mortality and significantly extended the life span of patients with AIDS. A variety of metabolic side effects are associated with these therapies, one of which is metabolic bone...

  • Young men on ART for HIV at risk for low bone mass.  // Infectious Disease News;Aug2012, Vol. 25 Issue 8, p6 

    The article focuses on the research conducted by researchers at research network Adolescent Medicine Trials Network (ATN) which shows that young men receiving antiretroviral therapy (ART) for HIV are likely to experience low bone mass.

  • Kaposi's sarcoma of the recto sigmoid colon in a patient with HIV infection and a high CD4 count. Acharya, S.; Ross, J. D. C. // International Journal of STD & AIDS;Jul2007, Vol. 18 Issue 7, p499 

    Kaposi's sarcoma (KS) is a well-recognized, HIV-associated opportunistic tumour, which was first described in 1872 by a Hungarian dermatologist, Moritz Kaposi. It predominantly affects homosexual men and heterosexual patients from Africa infected with HIV. The lesions can arise anywhere in the...

  • Starting antiretrovirals at any CD4 count appears to cut overall death risk.  // HIV Treatment ALERTS!;Apr2010, p27 

    The article presents a study which investigates the association of antiretroviral therapy with the risk of deaths among AIDS and non-AIDS patients. It states that information on adults subjects for 12 ongoing HIV studies were analyzed using the statistical method to determine how factors such as...

  • Reduced Quantitative Ultrasound Bone Mineral Density in HIV-Infected Patients on Antiretroviral Therapy in Senegal. Cournil, Amandine; Eymard-Duvernay, Sabrina; Diouf, Assane; Moquet, Claire; Coutherut, Julie; Gueye, Nd�ye Fatou Ngom; Cames, C�cile; Taverne, Bernard; Bork, Kirsten; Sow, Papa Salif; Delaporte, Eric // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: Bone status in HIV-infected patients on antiretroviral treatment (ART) is poorly documented in resource-limited settings. We compared bone mineral density between HIV-infected patients and control subjects from Dakar, Senegal. Methods: A total of 207 (134 women and 73 men)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics